We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LMLLF market cap is 2.19M. The company's latest EPS is CAD -0.1015 and P/E is -0.20.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 610k | 837k | 495k | 215k |
| Operating Income | -467k | -3.35M | -1.98M | -3.18M | -3.01M |
| Net Income | -3.89M | -6.79M | -5.22M | -5.63M | -8.88M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.06M | 10.38M | 13.69M | 19.52M | 12.11M |
| Total Liabilities | 1.55M | 5.92M | 3.12M | 2.66M | 3.28M |
| Total Equity | -491k | 4.46M | 10.57M | 16.87M | 8.84M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.29M | -2.34M | -1.41M | -4.13M | -2.26M |
| Investing | -774k | -7.32M | 3.78M | 1.48M | 78k |
| Financing | 1.77M | 9.51M | 132k | 777k | 843k |
| Market Cap | 2.19M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 8 |
| Price to Cash Ratio | 200 |
| Price to Book Ratio | 0.2 |
| Dividend Yield | - |
| Shares Outstanding | 87.44M |
| Average Volume (1 week) | 6.15k |
| Average Volume (1 Month) | 47.65k |
| 52 Week Change | -47.48% |
| 52 Week High | 0.0644 |
| 52 Week Low | 0.0148 |
| Spread (Intraday) | 0.01 (18.57%) |
| Company Name | Pharmadrug Inc (PK) |
| Address |
77 king street west, suite 2905 toronto, ontario M5K 1H1 |
| Website | https://www.pharmadrug.ca |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
